Copyright
©The Author(s) 2016.
World J Gastrointest Surg. Feb 27, 2016; 8(2): 124-133
Published online Feb 27, 2016. doi: 10.4240/wjgs.v8.i2.124
Published online Feb 27, 2016. doi: 10.4240/wjgs.v8.i2.124
Ref. | Date (yr) | Total cases (center involved) | Interval1(d) | FLR hypertrophy (median) | Completion stage 2 | R0 resection | PHLF | Morbidity2 | In-hospital mortality | Follow-up (median, months) | Recurrence | Overall survival |
Schnitzbauer et al[1] | 2012 | 25 (5) | 9 | 74% | 88% | 96% | - | Overall: 64% ≥ III: 40% | 12% | 6 | 20% | 86% at 6 m |
Torres et al[29] | 2013 | 39 (9) | 14 | 83% | 94.80% | 100% | - | Overall: 59% | 12.80% | - | - | - |
Schadde et al[10] | 2014 | 202 (56) | 7 | 80% | 98% | 91% | - | ≥ III: 40% | 9% | 9 | 40% at 12 m | 73% at 12 m |
Truant et al[4] | 2015 | 62 (9) | 8 | 48.60% | 95.20% | - | 25.8% | ≥ III: 40.3% | 12.90% | - | - | - |
Robles et al[11] | 2014 | 22 (1) | 7 | 61% | 100% | 100% | 22.7% | Overall: 64% | 9% | 6 | 5% | 91% at 6 m |
Nadalin et al[53] | 2014 | 15 (1) | 10 | 87.20% | 100% | 87% | - | Overall: 67% | 28.70% | 17 | 29% | 67% at 17 m |
Alvarez et al[15] | 2015 | 30 (1) | 6 | 89.70% | 93% | 93% | 14% | Overall: 53% ≥ III: 43% | 6.60% | 17 | 22% at 12 m | 67% at 12 m |
Petrowsky et al[16] | 2015 | 24 (1) | 7 | 61% | 100% | - | - | ≥ IIIb: 33% | 16.70% | - | - | - |
Hernandez- Alejandro et al[17] | 2015 | 14 (1) | 7 | 93% | 100% | 86% | 29% | Overall: 36% ≥ IIIb: 14% | 0% | 9 | 14% | 100% at 9 m |
Tanaka et al[21] | 2015 | 11 (1) | 7 | 54% | 100% | 100% (R0/R1) | 18% | Overall: 46% ≥ III: 27% | 9% | - | - | - |
Chan et al[50] | 2015 | 17 (1) | 6 | 48.70% | 100% | - | - | ≥ III: 11.8% | 5.90% | - | - | - |
- Citation: Li J, Ewald F, Gulati A, Nashan B. Associating liver partition and portal vein ligation for staged hepatectomy: From technical evolution to oncological benefit. World J Gastrointest Surg 2016; 8(2): 124-133
- URL: https://www.wjgnet.com/1948-9366/full/v8/i2/124.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v8.i2.124